-
1
-
2
The Mucolipin TRPML2 Channel Enhances the Sensitivity of Multiple Myeloma Cell Lines to Ibrutinib and/or Bortezomib Treatment
Published 2022-01-01Subjects: Get full text
Article -
3
Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells
Published 2018-11-01Subjects: “…TRPML2…”
Get full text
Article